GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 38 filers reported holding GENOCEA BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | 0.0% | 5,847 | -3.5% | 0.00% | – |
| Q4 2021 | $7,000 | -36.4% | 6,058 | +2.6% | 0.00% | – |
| Q3 2021 | $11,000 | -45.0% | 5,902 | -31.2% | 0.00% | -100.0% |
| Q2 2021 | $20,000 | -16.7% | 8,574 | -3.7% | 0.00% | – |
| Q1 2021 | $24,000 | -33.3% | 8,902 | -40.2% | 0.00% | -100.0% |
| Q4 2020 | $36,000 | +1100.0% | 14,893 | +890.2% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 1,504 | +41.2% | 0.00% | – |
| Q2 2019 | $4,000 | – | 1,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |